REGULATORY
9 Apr 2026
INNOVATION
8 Apr 2026
PARTNERSHIPS
7 Apr 2026
INVESTMENT
6 Apr 2026

PARTNERSHIPS
31 Mar 2026
Cellipont and Soter Bio launch an integrated US platform linking GMP RNA production to cell therapy manufacturing

REGULATORY
18 Dec 2025
HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies

INNOVATION
17 Dec 2025
New AI research forecasts mRNA protein output earlier, helping developers refine drug designs before costly lab testing begins

INVESTMENT
15 Dec 2025
Moderna secures a $1.5B non-dilutive term loan to fund mRNA growth beyond COVID, highlighting why established players may prioritize long-...

INNOVATION
12 Dec 2025
Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, ...

MARKET TRENDS
11 Dec 2025
Big players push mRNA into new arenas while early pipelines and selective deals shape the next wave

TECHNOLOGY
10 Dec 2025
Raina and Sanofi push AI powered mRNA design, revealing an early gap between predictive and generative tools
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.